Gilead Sciences Inc
(GILD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,330,000 | 5,144,000 | 7,926,000 | 9,991,000 | 5,037,000 |
| Marketable Securities | 19,000 | 69,000 | N/A | N/A | N/A |
| Receivables | 5,095,000 | 4,781,000 | 4,388,000 | 4,420,000 | 4,587,000 |
| Inventories | 1,785,000 | 1,825,000 | 1,759,000 | 1,710,000 | 1,869,000 |
| Other current assets | 0 | 0 | 0 | 0 | -1,000 |
| TOTAL | $17,874,000 | $14,718,000 | $16,901,000 | $19,173,000 | $14,779,000 |
| Non-Current Assets | |||||
| PPE Net | 5,500,000 | 5,459,000 | 5,421,000 | 5,414,000 | 5,391,000 |
| Investments And Advances | 2,005,000 | 1,913,000 | 0 | 0 | 0 |
| Intangibles | 26,284,000 | 26,880,000 | 27,669,000 | 28,262,000 | 28,860,000 |
| Other Non-Current Assets | 6,871,000 | 6,752,000 | 6,443,000 | 6,147,000 | 5,494,000 |
| TOTAL | $40,660,000 | $41,004,000 | $39,533,000 | $39,823,000 | $39,745,000 |
| Total Assets | $58,533,000 | $55,721,000 | $56,434,000 | $58,995,000 | $54,525,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,806,000 | 2,806,000 | 2,806,000 | 1,815,000 | 1,812,000 |
| Accounts payable and accrued liabilities | 808,000 | 582,000 | 737,000 | 833,000 | 903,000 |
| Accrued Expenses | 4,931,000 | 4,215,000 | 4,185,000 | 3,892,000 | 4,113,000 |
| Other current liabilities | 3,752,000 | 3,586,000 | 4,615,000 | 5,464,000 | 4,896,000 |
| TOTAL | $12,298,000 | $11,189,000 | $12,344,000 | $12,004,000 | $11,725,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,135,000 | 22,140,000 | 22,146,000 | 24,896,000 | 22,833,000 |
| Other Non-Current Liabilities | 2,048,000 | 2,149,000 | 2,156,000 | 2,125,000 | 782,000 |
| TOTAL | $24,780,000 | $24,941,000 | $25,011,000 | $27,745,000 | $24,409,000 |
| Total Liabilities | $37,077,000 | $36,131,000 | $37,356,000 | $39,749,000 | $36,135,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,240,680 | 1,240,807 | 1,243,929 | 1,245,346 | 1,246,266 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 12,825,000 | 11,325,000 | 10,931,000 | 11,497,000 | 11,073,000 |
| Other shareholders' equity | -48,000 | -103,000 | 8,000 | 48,000 | -11,000 |
| TOTAL | $21,456,000 | $19,590,000 | $19,078,000 | $19,246,000 | $18,390,000 |
| Total Liabilities And Equity | $58,533,000 | $55,721,000 | $56,434,000 | $58,995,000 | $54,525,000 |